Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Actuate Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 61 | 1 | 62 | +2 |
| Shares | 13.9M | 1.87K | 13.4M | −415.6K (−3.0%) |
| Value | $38.0M | $5.12K | $20.6M | −$17.4M (−45.8%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Actuate Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 96,684 | $147.9K | 0.00% |
| ABS Investment Management LLC | 73,186 | $112.0K | 0.09% |
| Jane Street Group, LLC | 39,132 | $59.9K | 0.00% |
| HighTower Advisors, LLC | 36,461 | $55.8K | 0.00% |
| Susquehanna International Group, LLP | 28,182 | $43.1K | 0.00% |
| Mariner, LLC | 21,082 | $32.3K | 0.00% |
| Qube Research & Technologies Ltd | 15,256 | $23.3K | 0.00% |
| Virtu Financial LLC | 14,611 | $22.0K | 0.00% |
| Apollon Wealth Management, LLC | 14,013 | $21.4K | 0.00% |
| Ieq Capital, LLC | 13,890 | $21.3K | 0.00% |
| HRT Financial LP | 14,034 | $21.0K | 0.00% |
| ACT Advisors, LLC. | 12,877 | $19.7K | 0.01% |
| Sowell Financial Services LLC | 10,973 | $16.8K | 0.00% |
| Green Ridge Wealth Planning LLC | 10,000 | $15.3K | 0.01% |
| Global Retirement Partners, LLC | 6,250 | $9.56K | 0.00% |
| Fortitude Family Office, LLC | 30 | $46 | 0.00% |
| JPL Wealth Management, LLC | 1 | $2 | 0.00% |
Sold out (15)
Institutions that held Actuate Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Connective Capital Management, LLC | 113,266 | $310.3K |
| Vanguard Portfolio Management LLC | 55,536 | $152.2K |
| ABS Direct Equity Fund LLC | 50,000 | $137.0K |
| Bank of New York Mellon Corp | 15,416 | $42.2K |
| XTX Topco Ltd | 15,118 | $41.4K |
| Charles Schwab Investment Management Inc | 11,146 | $30.5K |
| Bank of America Corp | 11,034 | $30.2K |
| New York State Common Retirement Fund | 6,200 | $17.0K |
| Mirae Asset Global ETFs Holdings Ltd. | 4,525 | $12.4K |
| Legal & General Group Plc | 1,107 | $3.03K |
| Ameritas Investment Partners, Inc. | 601 | $1.65K |
| Sterling Capital Management LLC | 40 | $110 |
| Wealth Preservation Advisors, LLC | 7 | $19 |
| MAI Capital Management | 6 | $17 |
| Root Financial Partners, LLC | 5 | $14 |
Not filed for Q2 2026 yet (1)
Institutions that held Actuate Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 1,867 | $5.12K |